{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:37:51Z","timestamp":1769600271351,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Older patients at risk of functional decline are frequently affected by polypharmacy. This is associated with a further loss of independence. However, a relationship between functional disability and medications, such as \u2018Potentially Inappropriate Medications\u2019 (PIMs) and \u2018Potential Prescribing Omissions\u2019 (PPOs), as itemised for (de) prescribing in practice-orientated medication lists, has yet to be established.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>As part of a randomised comparative effectiveness trial, <jats:italic>LoChro<\/jats:italic>, we conducted a cross-sectional analysis of the association between PIMs and PPOs measured using the \u2018Screening Tool of Older Persons\u2019 Prescription Criteria \/ Screening Tool To Alert to Right Treatment\u2019 (STOPP\/START) Version 2, with functional disability assessed using the \u2018World Health Organization Disability Assessment Schedule 2.0\u2019 (WHODAS). Individuals aged 65 and older at risk of loss of independence were recruited from the inpatient and outpatient departments of the local university hospital. Multiple linear regression analysis was used to model the potential prediction of functional disability using the numbers of PIMs and PPOs, adjusted for confounders including multimorbidity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of 461 patients, both the number of PIMs and the number of PPOs were significantly associated with an increase in WHODAS-score (Regression coefficients B 2.7 [95% confidence interval: 1.5-3.8] and 1.5 [95% confidence interval: 0.2-2.7], respectively). In WHODAS-score prediction modelling the contribution of the number of PIMs exceeded the one of multimorbidity (standardised coefficients beta: PIM 0.20; multimorbidity 0.13; PPO 0.10), whereas no significant association between the WHODAS-score and the number of medications was seen. 73.5 % (339) of the participants presented with at least one PIM, and 95.2% (439) with at least one PPO. The most common PIMs were proton pump inhibitors and analgesic medication, with frequent PPOs being pneumococcal and influenza vaccinations, as well as osteoporosis prophylaxis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The results indicate a relationship between inappropriate prescribing, both PIMs and PPOs, and functional disability, in older patients at risk of further decline. Long-term analysis may help clarify whether these patients benefit from interventions to reduce PIMs and PPOs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-022-03242-w","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T08:02:51Z","timestamp":1657180971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany \u2013 a cross-sectional survey conducted as part of a randomised comparative effectiveness trial"],"prefix":"10.1186","volume":"22","author":[{"given":"Claudia","family":"Salm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Pfefferle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Sofroniou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Metzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Farin-Glattacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Voigt-Radloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Maun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"3242_CR1","doi-asserted-by":"crossref","unstructured":"Khezrian M, McNeil CJ, Murray AD, Myint PK. An overview of prevalence, determinants and health outcomes of polypharmacy. Ther Adv Drug Saf. 2020;12 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7294476\/.","DOI":"10.1177\/2042098620933741"},{"issue":"7","key":"3242_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jamda.2017.02.009","volume":"18","author":"N Veronese","year":"2017","unstructured":"Veronese N, Stubbs B, Noale M, Solmi M, Pilotto A, Vaona A. Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study. J Am Med Dir Assoc. 2017;18(7):624\u20138.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"3242_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/ggi.12241","volume":"15","author":"F Sganga","year":"2015","unstructured":"Sganga F, Landi F, Ruggiero C, Corsonello A, Vetrano DL, Lattanzio F, et al. Polypharmacy and health outcomes among older adults discharged from hospital: Results from the CRIME study. Geriatr Gerontol Int. 2015;15(2):141\u20136.","journal-title":"Geriatr Gerontol Int"},{"issue":"6","key":"3242_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.japh.2017.06.002","volume":"57","author":"N Leelakanok","year":"2017","unstructured":"Leelakanok N, Holcombe AL, Lund BC, Gu X, Schweizer ML. Association between polypharmacy and death: A systematic review and meta-analysis. J Am Pharm Assoc. 2017;57(6):729\u2013738.e10.","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"3242_CR5","doi-asserted-by":"publisher","first-page":"e0171320","DOI":"10.1371\/journal.pone.0171320","volume":"12","author":"A Montiel-Luque","year":"2017","unstructured":"Montiel-Luque A, N\u00fa\u00f1ez-Montenegro AJ, Mart\u00edn-Aurioles E, Canca-S\u00e1nchez JC, Toro-Toro MC, Gonz\u00e1lez-Correa JA. Medication-related factors associated with health-related quality of life in patients older than 65 years with polypharmacy. PLoS One. 2017;12(2):e0171320.","journal-title":"PLoS One"},{"key":"3242_CR6","doi-asserted-by":"crossref","unstructured":"Rieckert A, Trampisch US, Klaa\u00dfen-Mielke R, Drewelow E, Esmail A, Johansson T. Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy. BMC Fam Pract. 2018;18 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6052592\/.","DOI":"10.1186\/s12875-018-0795-5"},{"issue":"3","key":"3242_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1345\/aph.1H473","volume":"41","author":"E Jano","year":"2007","unstructured":"Jano E, Aparasu RR. Healthcare Outcomes Associated with Beers\u2019 Criteria: A Systematic Review. Ann Pharmacother. 2007;41(3):438\u201348.","journal-title":"Ann Pharmacother"},{"issue":"8","key":"3242_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40266-020-00767-w","volume":"37","author":"A De Vincentis","year":"2020","unstructured":"De Vincentis A, Gallo P, Finamore P, Pedone C, Costanzo L, Pasina L. Potentially Inappropriate Medications, Drug\u2013Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes? Drugs Aging. 2020;37(8):585\u201393.","journal-title":"Drugs Aging"},{"key":"3242_CR9","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2019;67(4):674\u201394.","DOI":"10.1111\/jgs.15767"},{"issue":"2","key":"3242_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213\u20138.","journal-title":"Age Ageing"},{"issue":"1","key":"3242_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/jgs.13884","volume":"64","author":"JD Brown","year":"2016","unstructured":"Brown JD, Hutchison LC, Li C, Painter JT, Martin BC. Predictive validity of the Beers and STOPP Criteria to detect adverse drug events, hospitalizations, and emergency department visits in the United States. J Am Geriatr Soc. 2016;64(1):22\u201330.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"3242_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/gerona\/glw140","volume":"72","author":"E Wallace","year":"2017","unstructured":"Wallace E, McDowell R, Bennett K, Fahey T, Smith SM. Impact of Potentially Inappropriate Prescribing on Adverse Drug Events, Health Related Quality of Life and Emergency Hospital Attendance in Older People Attending General Practice: A Prospective Cohort Study. J Gerontol Ser A. 2017;72(2):271\u20137.","journal-title":"J Gerontol Ser A"},{"key":"3242_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.archger.2018.05.007","volume":"77","author":"P Fabbietti","year":"2018","unstructured":"Fabbietti P, Ruggiero C, Sganga F, Fusco S, Mammarella F, Barbini N. Effects of hyperpolypharmacy and potentially inappropriate medications (PIMs) on functional decline in older patients discharged from acute care hospitals. Arch Gerontol Geriatr. 2018;77:158\u201362.","journal-title":"Arch Gerontol Geriatr"},{"key":"3242_CR14","doi-asserted-by":"publisher","first-page":"f7033","DOI":"10.1136\/bmj.f7033","volume":"347","author":"J Wise","year":"2013","unstructured":"Wise J. Polypharmacy: a necessary evil. BMJ. 2013;347:f7033.","journal-title":"BMJ"},{"issue":"10","key":"3242_CR15","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00228-017-2293-4","volume":"73","author":"B Cossette","year":"2017","unstructured":"Cossette B, \u00c9thier JF, Joly-Mischlich T, Bergeron J, Ricard G, Brazeau S. Reduction in targeted potentially inappropriate medication use in elderly inpatients: a pragmatic randomized controlled trial. Eur J Clin Pharmacol. 2017;73(10):1237\u201345.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"3242_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2296-11-65","volume":"11","author":"S Anthierens","year":"2010","unstructured":"Anthierens S, Tansens A, Petrovic M, Christiaens T. Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract. 2010;11(1):65.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"3242_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1365-2125.2007.02961.x","volume":"65","author":"MAJ Kuijpers","year":"2008","unstructured":"Kuijpers MAJ, van Marum RJ, Egberts ACG, Jansen PAF. OLDY (OLd people Drugs & dYsregulations) Study Group. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol. 2008;65(1):130\u20133.","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"3242_CR18","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1345\/aph.1M157","volume":"43","author":"C Ryan","year":"2009","unstructured":"Ryan C, O\u2019Mahony D, Byrne S. Application of STOPP and START criteria: interrater reliability among pharmacists. Ann Pharmacother. 2009;43(7):1239\u201344.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"3242_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-020-1432-4","volume":"20","author":"K Cardwell","year":"2020","unstructured":"Cardwell K, Kerse N, Hughes CM, Teh R, Moyes SA, Menzies O, et al. Does potentially inappropriate prescribing predict an increased risk of admission to hospital and mortality? A longitudinal study of the \u2018oldest old\u2019. BMC Geriatr. 2020;20(1):1\u20139.","journal-title":"BMC Geriatr"},{"issue":"7","key":"3242_CR20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00228-018-2452-2","volume":"74","author":"M Guti\u00e9rrez-Valencia","year":"2018","unstructured":"Guti\u00e9rrez-Valencia M, Izquierdo M, Lacalle-Fabo E, Mar\u00edn-Epelde I, Ram\u00f3n-Espinoza MF, Domene-Domene T. Relationship between frailty, polypharmacy, and underprescription in older adults living in nursing homes. Eur J Clin Pharmacol. 2018;74(7):961\u201370.","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"3242_CR21","doi-asserted-by":"publisher","first-page":"e0136339","DOI":"10.1371\/journal.pone.0136339","volume":"10","author":"AD Meid","year":"2015","unstructured":"Meid AD, Quinzler R, Freigofas J, Saum KU, Sch\u00f6ttker B, Holleczek B, et al. Medication Underuse in Aging Outpatients with Cardiovascular Disease: Prevalence, Determinants, and Outcomes in a Prospective Cohort Study. PLoS One. 2015;10(8):e0136339.","journal-title":"PLoS One"},{"issue":"3","key":"3242_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ejcn.2015.196","volume":"70","author":"M Naseer","year":"2016","unstructured":"Naseer M, Forssell H, Fagerstr\u00f6m C. Malnutrition, functional ability and mortality among older people aged \u2a7e 60 years: a 7-year longitudinal study. Eur J Clin Nutr. 2016;70(3):399\u2013404.","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"3242_CR23","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/ijerph17031006","volume":"17","author":"I Tornero-Qui\u00f1ones","year":"2020","unstructured":"Tornero-Qui\u00f1ones I, S\u00e1ez-Padilla J, Espina D\u00edaz A, Abad Robles MT, Sierra Robles \u00c1. Functional Ability, Frailty and Risk of Falls in the Elderly: Relations with Autonomy in Daily Living. Int J Environ Res Public Health. 2020;17(3):1006.","journal-title":"Int J Environ Res Public Health"},{"issue":"5\u20136","key":"3242_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/BF03324941","volume":"22","author":"C Fagerstr\u00f6m","year":"2010","unstructured":"Fagerstr\u00f6m C, Borglin G. Mobility, functional ability and health-related quality of life among people of 60 years or older. Aging Clin Exp Res. 2010;22(5\u20136):387\u201394.","journal-title":"Aging Clin Exp Res"},{"key":"3242_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.puhe.2019.10.014","volume":"180","author":"S Kelso","year":"2020","unstructured":"Kelso S, Mitchell S, Rowe PJ, Gore P. The Scottish national LifeCurveTM survey: costs of functional decline, opportunities to achieve early intervention to support well-being in later life, and meaningfulness of the LifeCurveTM. Public Health. 2020;180:129\u201335.","journal-title":"Public Health"},{"issue":"2","key":"3242_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/gerona\/63.2.160","volume":"63","author":"Working Group on Functional Outcome Measures for Clinical Trials","year":"2008","unstructured":"Working Group on Functional Outcome Measures for Clinical Trials. Functional Outcomes for Clinical Trials in Frail Older Persons: Time To Be Moving. J Gerontol A Biol Sci Med Sci. 2008;63(2):160\u20134.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"3242_CR27","doi-asserted-by":"crossref","unstructured":"Frank F, Bjerregaard F, Bengel J, Bitzer EM, Heimbach B, Kaier K. Local, collaborative, stepped and personalised care management for older people with chronic diseases (LoChro): study protocol of a randomised comparative effectiveness trial. BMC Geriatr. 2019;4.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6398245\/.","DOI":"10.1186\/s12877-019-1088-0"},{"issue":"9","key":"3242_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1553-2712.1998.tb02818.x","volume":"5","author":"J McCusker","year":"1998","unstructured":"McCusker J, Bellavance F, Cardin S, Tr\u00e9panier S. Screening for geriatric problems in the emergency department: reliability and validity. Identification of Seniors at Risk (ISAR) Steering Committee. Acad Emerg Med. 1998;5(9):883\u201393.","journal-title":"Acad Emerg Med"},{"issue":"5","key":"3242_CR29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000358825","volume":"60","author":"K Singler","year":"2014","unstructured":"Singler K, Heppner HJ, Skutetzky A, Sieber C, Christ M, Thiem U. Predictive validity of the identification of seniors at risk screening tool in a German emergency department setting. Gerontology. 2014;60(5):413\u20139.","journal-title":"Gerontology"},{"key":"3242_CR30","unstructured":"Organization WH. International classification of diseases and related health problems, 10^<th> revision. http:\/\/www.who.int\/classifications\/apps\/icd\/icd10online [Internet]. 2007 https:\/\/ci.nii.ac.jp\/naid\/10024668523\/"},{"key":"3242_CR31","unstructured":"WHOCC - ATC\/DDD Index [Internet].: https:\/\/www.whocc.no\/atc_ddd_index\/"},{"issue":"12","key":"3242_CR32","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/14740338.2018.1546841","volume":"17","author":"JW Wastesson","year":"2018","unstructured":"Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185\u201396.","journal-title":"Expert Opin Drug Saf"},{"key":"3242_CR33","doi-asserted-by":"publisher","first-page":"m160","DOI":"10.1136\/bmj.m160","volume":"368","author":"LE Stirland","year":"2020","unstructured":"Stirland LE, Gonz\u00e1lez-Saavedra L, Mullin DS, Ritchie CW, Muniz-Terrera G, Russ TC. Measuring multimorbidity beyond counting diseases: systematic review of community and population studies and guide to index choice. BMJ. 2020;368:m160.","journal-title":"BMJ"},{"issue":"2","key":"3242_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2007.05.015","volume":"61","author":"L Tooth","year":"2008","unstructured":"Tooth L, Hockey R, Byles J, Dobson A. Weighted multimorbidity indexes predicted mortality, health service use, and health-related quality of life in older women. J Clin Epidemiol. 2008;61(2):151\u20139.","journal-title":"J Clin Epidemiol"},{"key":"3242_CR35","unstructured":"Organization WH. Measuring Health and Disability: Manual for WHO Disability Assessment Schedule WHODAS 2.0. World Health Organization; 2010. 145 S."},{"issue":"9","key":"3242_CR36","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s11136-007-9259-4","volume":"16","author":"M P\u00f6sl","year":"2007","unstructured":"P\u00f6sl M, Cieza A, Stucki G. Psychometric properties of the WHODASII in rehabilitation patients. Qual Life Res. 2007;16(9):1521\u201331.","journal-title":"Qual Life Res"},{"issue":"6","key":"3242_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"5","key":"3242_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/165019701750419545","volume":"33","author":"G Grimby","year":"2001","unstructured":"Grimby G, Smedby B. ICF approved as the successor of ICIDH. J Rehabil Med. 2001;33(5):193\u20134.","journal-title":"J Rehabil Med."},{"issue":"1","key":"3242_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1477-7525-8-51","volume":"8","author":"O Garin","year":"2010","unstructured":"Garin O, Ayuso-Mateos JL, Almansa J, Nieto M, Chatterji S, Vilagut G. Validation of the \u201cWorld Health Organization Disability Assessment Schedule, WHODAS-2\u201d in patients with chronic diseases. Health Qual Life Outcomes. 2010;8(1):51.","journal-title":"Health Qual Life Outcomes"},{"key":"3242_CR40","doi-asserted-by":"crossref","unstructured":"Mid\u00e3o L, Brochado P, Almada M, Duarte M, Pa\u00fal C, Costa E. Frailty Status and Polypharmacy Predict All-Cause Mortality in Community Dwelling Older Adults in Europe. Int J Environ Res Public Health. 2021; https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8036295\/.","DOI":"10.3390\/ijerph18073580"},{"issue":"4","key":"3242_CR41","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1177\/0898264314558202","volume":"27","author":"D Basic","year":"2015","unstructured":"Basic D, Shanley C. Frailty in an Older Inpatient Population: Using the Clinical Frailty Scale to Predict Patient Outcomes. J Aging Health. 2015;27(4):670\u201385.","journal-title":"J Aging Health"},{"issue":"4","key":"3242_CR42","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s00103-012-1464-9","volume":"55","author":"J Fuchs","year":"2012","unstructured":"Fuchs J, Busch M, Lange C, Scheidt-Nave C. Prevalence and patterns of morbidity among adults in Germany. Results of the German telephone health interview survey German Health Update (GEDA) 2009. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55(4):576\u201386.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz."},{"key":"3242_CR43","doi-asserted-by":"crossref","unstructured":"Puth MT, Weckbecker K, Schmid M, M\u00fcnster E. Prevalence of multimorbidity in Germany: impact of age and educational level in a cross-sectional study on 19,294 adults. BMC Public Health. 2017; https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5648462\/.","DOI":"10.1186\/s12889-017-4833-3"},{"issue":"11","key":"3242_CR44","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00228-011-1061-0","volume":"67","author":"P Gallagher","year":"2011","unstructured":"Gallagher P, Lang PO, Cherubini A, Topinkov\u00e1 E, Cruz-Jentoft A, Montero Errasqu\u00edn B. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol. 2011;67(11):1175\u201388.","journal-title":"Eur J Clin Pharmacol"},{"key":"3242_CR45","unstructured":"Robert Koch-Institut. St\u00e4ndige Impfkommission (STIKO) am RKI Wissenschaftliche Begr\u00fcndung f\u00fcr die Aktualisierung der Pneumokokken-Impfempfehlung f\u00fcr Senioren. 2016 http:\/\/edoc.rki.de\/docviews\/abstract.php?lang=ger&id=4549"},{"key":"3242_CR46","doi-asserted-by":"crossref","unstructured":"Endres HG, Kaufmann-Kolle P, Steeb V, Bauer E, B\u00f6ttner C, Th\u00fcrmann P. Association between Potentially Inappropriate Medication (PIM) Use and Risk of Hospitalization in Older Adults: An Observational Study Based on Routine Data Comparing PIM Use with Use of PIM Alternatives. PLoS One. 2016; https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4740421\/.","DOI":"10.1371\/journal.pone.0146811"},{"key":"3242_CR47","unstructured":"Koch-Institut R. Epidemiologisches Bulletin 47\/2020. November. 2020;34."},{"issue":"969","key":"3242_CR48","first-page":"195","volume":"05","author":"OA Sawicki","year":"2021","unstructured":"Sawicki OA, M\u00fcller A, Glushan A, Klaa\u00dfen-Mielke R, Gerlach FM, Beyer M. Influenza-Impfrate in der \u00e4lteren Bev\u00f6lkerung in und au\u00dferhalb der HZV in Baden-W\u00fcrttemberg - Online ZFA. 05. 14. Mai. 2021;05(969):195.","journal-title":"Mai"},{"issue":"2","key":"3242_CR49","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s41999-020-00420-0","volume":"12","author":"C Avgerinou","year":"2021","unstructured":"Avgerinou C, Kotsani M, Gavana M, Andreou M, Papageorgiou DI, Roka V, et al. Perceptions, attitudes and training needs of primary healthcare professionals in identifying and managing frailty: a qualitative study. Eur Geriatr Med. 2021;12(2):321\u201332.","journal-title":"Eur Geriatr Med"},{"issue":"7","key":"3242_CR50","doi-asserted-by":"publisher","first-page":"426","DOI":"10.31128\/AJGP-11-18-4757","volume":"48","author":"RC Ambagtsheer","year":"2019","unstructured":"Ambagtsheer RC, Archibald MM, Lawless M, Mills D, Yu S, Beilby JJ. General practitioners\u2019 perceptions, attitudes and experiences of frailty and frailty screening. Aust J Gen Pract. 2019;48(7):426\u201333.","journal-title":"Aust J Gen Pract"},{"issue":"9","key":"3242_CR51","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s11606-019-05106-3","volume":"34","author":"A Katsimpris","year":"2019","unstructured":"Katsimpris A, Linseisen J, Meisinger C, Volaklis K. The Association Between Polypharmacy and Physical Function in Older Adults: a Systematic Review. J Gen Intern Med. 2019;34(9):1865\u201373.","journal-title":"J Gen Intern Med"},{"key":"3242_CR52","unstructured":"Schiavo G, Forgerini M, Lucchetta RC, Mastroianni P de C. A comprehensive look at explicit screening tools for potentially inappropriate medication: A systematic scoping review. Australasian Journal on Ageing https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/ajag.13046"},{"key":"3242_CR53","unstructured":"Hospices Civils de Lyon. Optimization of Drug Prescribing in an Elderly Population of Geriatric Consultations and Living at Home [Internet]. clinicaltrials.gov; 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02740764"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-022-03242-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-022-03242-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-022-03242-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T08:03:10Z","timestamp":1657180990000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-022-03242-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3242"],"URL":"https:\/\/doi.org\/10.1186\/s12877-022-03242-w","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The study was approved by the ethical committee of the University of Freiburg (Ethical vote 495\/17). All participants or their legal representatives gave written informed consent prior to participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"564"}}